AU Patent

AU2011307608B2 — Crystalline naloxol-PEG conjugate

Assigned to Gruenenthal GmbH · Expires 2015-04-09 · 11y expired

What this patent protects

Naloxol-polyethlyene glycol conjugates of the formula:are provided in oxalate or phosphate salt forms including crystalline forms. Methods of preparing the salt forms and pharmaceutical compositions comprising the salt forms are also provided.

USPTO Abstract

Naloxol-polyethlyene glycol conjugates of the formula:are provided in oxalate or phosphate salt forms including crystalline forms. Methods of preparing the salt forms and pharmaceutical compositions comprising the salt forms are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011307608B2
Jurisdiction
AU
Classification
Expires
2015-04-09
Drug substance claim
No
Drug product claim
No
Assignee
Gruenenthal GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.